Literature DB >> 18950864

Two factors of the lectin pathway of complement, l-ficolin and mannan-binding lectin, and their associations with prematurity, low birthweight and infections in a large cohort of Polish neonates.

Anna St Swierzko1, Anne P M Atkinson, Maciej Cedzynski, Shirley L Macdonald, Agnieszka Szala, Iwona Domzalska-Popadiuk, Monika Borkowska-Klos, Aleksandra Jopek, Jerzy Szczapa, Misao Matsushita, Janusz Szemraj, Marc L Turner, David C Kilpatrick.   

Abstract

Ficolins and one collectin, mannan-binding lectin (MBL), are the only factors known to activate the lectin pathway (LP) of complement. There is considerable circumstantial evidence that MBL insufficiency can increase susceptibility to various infections and influence the course of several non-infectious diseases complicated by infections. Much less information is available concerning l-ficolin. We report the results of a prospective study to investigate any association between either MBL deficiency or l-ficolin deficiency with prematurity, low birthweight or perinatal infections in a large cohort of Polish neonates, representing an ethnically homogenous population (n=1832). Cord blood samples were analysed to determine mbl-2 gene variants, MBL concentrations and MBL-MASP-2 complex activities (MBL-dependent lectin pathway activity) as well as l-ficolin levels. Median concentrations of l-ficolin and MBL were 2500 and 1124 ng/ml, respectively, while median LP activity was 272 mU/ml. After genotyping, 60.6% of babies were mbl-2 A/A, 35.4% were A/O and 4% were O/O genotypes. We found relative l-ficolin deficiency to be associated with prematurity, low birthweight and infections. l-Ficolin concentration correlated with gestational age and with birthweight, independently of gestational age. Preterm deliveries (<38 weeks) occurred more frequently among neonates with low LP activity but not with those having low serum MBL levels. Similarly, no association of serum MBL deficiency with low birthweight was found, but there was a correlation between LP activity and birthweight. Genotypes conferring very low serum MBL concentrations were associated with perinatal infections, and high-MBL-conferring genotypes were associated with prematurity. Our findings suggest that l-ficolin participates in host defence during the perinatal period and constitute the first evidence that relative l-ficolin deficiency may contribute to the adverse consequences of prematurity. Some similar trends were found with facets of MBL deficiency, but the observed relationships were weaker and less consistent.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18950864     DOI: 10.1016/j.molimm.2008.07.025

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  21 in total

1.  L-ficolin and capsular polysaccharide-specific IgG in cord serum contribute synergistically to opsonophagocytic killing of serotype III and V group B streptococci.

Authors:  Mioko Fujieda; Youko Aoyagi; Kousaku Matsubara; Yasuhito Takeuchi; Wakae Fujimaki; Misao Matsushita; John F Bohnsack; Shinji Takahashi
Journal:  Infect Immun       Date:  2012-03-26       Impact factor: 3.441

2.  Gene expression profiling reveals candidate genes related to residual feed intake in duodenum of laying ducks.

Authors:  T Zeng; L Huang; J Ren; L Chen; Y Tian; Y Huang; H Zhang; J Du; L Lu
Journal:  J Anim Sci       Date:  2017-12       Impact factor: 3.159

3.  Early elevations of the complement activation fragment C3a and adverse pregnancy outcomes.

Authors:  Anne M Lynch; Ronald S Gibbs; James R Murphy; Patricia C Giclas; Jane E Salmon; V Michael Holers
Journal:  Obstet Gynecol       Date:  2011-01       Impact factor: 7.661

4.  Circulating ficolin-2 and ficolin-3 in normal pregnancy and pre-eclampsia.

Authors:  A Halmos; J Rigó; J Szijártó; G Füst; Z Prohászka; A Molvarec
Journal:  Clin Exp Immunol       Date:  2012-07       Impact factor: 4.330

Review 5.  Factors of the lectin pathway of complement activation and their clinical associations in neonates.

Authors:  Maciej Cedzynski; Anna St Swierzko; David C Kilpatrick
Journal:  J Biomed Biotechnol       Date:  2012-03-22

Review 6.  Human L-ficolin (ficolin-2) and its clinical significance.

Authors:  David C Kilpatrick; James D Chalmers
Journal:  J Biomed Biotechnol       Date:  2012-02-28

Review 7.  The lectin pathway of complement and rheumatic heart disease.

Authors:  Marcia Holsbach Beltrame; Sandra Jeremias Catarino; Isabela Goeldner; Angelica Beate Winter Boldt; Iara José de Messias-Reason
Journal:  Front Pediatr       Date:  2015-01-21       Impact factor: 3.418

8.  Association of L-ficolin levels and FCN2 genotypes with chronic Chagas disease.

Authors:  Paola R Luz; Angelica B W Boldt; Caroline Grisbach; Jürgen F J Kun; Thirumalaisamy P Velavan; Iara J T Messias-Reason
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

9.  The immune consequences of preterm birth.

Authors:  Jacqueline M Melville; Timothy J M Moss
Journal:  Front Neurosci       Date:  2013-05-21       Impact factor: 4.677

Review 10.  Soluble mediators regulating immunity in early life.

Authors:  Matthew Aaron Pettengill; Simon Daniël van Haren; Ofer Levy
Journal:  Front Immunol       Date:  2014-09-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.